Josh Wolfe

Josh co-founded Lux Capital to support scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of

Josh Wolfe
new-york-new-york

Josh co-founded Lux Capital to support scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of our time in order to lead us into a brighter future. The more ambitious the project, the better—like, say, creating matter from light. Josh is a Director at Shapeways, Strateos, Lux Research, Kallyope, CTRL-labs, Variant, and Varda, and helped lead the firm’s investments in Anduril, Planet, Echodyne, Clarifai, Authorea, Resilience and Hadrian. He is a founding investor and board member with Bill Gates in Kymeta, making cutting-edge antennas for high-speed global satellite and space communications.

Investment Focus
Stages
Seed
Series B+
Series A
Markets
SaaS / Enterprise
Fintech
AI / ML
Healthcare
Logistics / Supply Chain
Portfolio Companies
Eikon Therapeutics, Runway, Aera Therapeutics, Anduril
Links
No public links
Contacts
Unlock contacts with credits
Share this page